.png)
Advisory Board
Our advisory board comprises esteemed experts who provide strategic guidance and insights to drive innovation and impact. With extensive experience in healthcare, policy, and industry leadership, our advisors support our mission to advance sustainable and effective solutions
.png)
Associate Professor Dr Jeremy Lim (MD, MPH)
Advisory Board Member
Dr Lim is currently the CEO of a microbiome company, AMiLi, and advises senior officials at public sector agencies. He has extensive experience consulting and advising multinational private and NGO clients on national and regional strategies for go-to-market plans and implementation, government engagement, and public-private partnerships. Dr. Jeremy holds appointments at (Saw Swee Hock School of Public Health, and Duke-NUS medical school).
Dr Jeremy also served as a partner in Oliver Wyman’s Health and Life-Science practice and was the CEO of Fortis Colorectal Hospital. He has worked in senior executive roles in both public and private sectors, including time spent as a senior official in the Ministry of Health where he was also involved in a number of ‘Whole of Government’ initiatives. Dr. Jeremy chairs the steering committee of NIHA (NUS Initiative to Improve Health in Asia), and sits on the Behavioral Sciences Institute SMU, Centre for Health Informatics (NUS), and Next Age Institute (NUS) advisory boards.
He also contributes as immediate past President of the Fulbright Association and convener for the Johns Hopkins Bloomberg School of Public Health Singapore alumni. Dr. Jeremy enjoys serving in the NGO sector, the medical advisory committee of Dover Park Hospice, and regionally is a Member of the ‘Save the Children’ Asia Corporate Advisory Council. He is also a volunteer physician with HealthServe.
Dr Natalia Salim Liem (PhD)
South East Asia Representative
Natalie Liem, PhD, serves as a Managing Director and esteemed member of our Advisory Board, bringing extensive expertise in medical devices. Dr. Liem holds a Bachelor of Science in Genetics and Microbiology, a Master of Science in Prenatal Genetics and Fetal Medicine, and a PhD in Childhood Leukemia from the School of Paediatrics. Her deep understanding of both the clinical and scientific aspects of medicine, coupled with her leadership experience, provides invaluable strategic guidance to our organization
.png)
Kevin Lim
South East Asia Representative
Kevin, holding a BSc in Computer Science and Management from the University of Liverpool, is a seasoned entrepreneur and strategic advisor. He has successfully co-founded and led a diverse portfolio of ventures, spanning e-commerce consulting, IT solutions development, advertising, web solutions, agriculture, and property development, achieving notable exits in the advertising and web solutions sectors. Since 2015, he has focused on providing hands-on advisory support to medical technology and education startups, including serving as a director at Perspectum Ltd. from 2020 to 2023. Kevin continues to maintain an influential presence, acting as an observer and active participant within the Asia office.
Carlos B Tessmar
Advisory Board Member
As the former Global CEO of Boehringer Ingelheim, a position he held until 1994, he provided visionary leadership that culminated in the strategic acquisition of Boehringer Ingelheim's ber division by Roche, a significant milestone in the company's history.
